Raymon Heather 4
4 · Artiva Biotherapeutics, Inc. · Filed May 19, 2026
Research Summary
AI-generated summary of this filing
Artiva Biotherapeutics (ARTV) SVP Raymon Heather Sells Shares
What Happened
Raymon Heather, Senior Vice President of Research and Development at Artiva Biotherapeutics (ARTV), sold 3,095 shares on 2026-05-19 in an open market/private sale. The reported total proceeds were $27,879. This transaction was a sale (not a purchase) and was executed to cover tax withholding related to the vesting/release of restricted stock units.
Key Details
- Transaction date: 2026-05-19 (filed same day)
- Transaction type/code: Sale (S) — sell-to-cover to satisfy tax withholding (automatic, not at the insider’s discretion) [Footnote F1]
- Shares sold: 3,095
- Price: weighted average $9.0078; reported range $8.7447–$9.0104 [Footnote F2]
- Proceeds: $27,879
- Shares owned after transaction: not disclosed in this filing
- Filing timeliness: filing date equals transaction date; no late filing indicated
- Additional note: issuer can provide full breakdown of number of shares sold at each separate price upon request (per F2)
Context
This sale was an automatic "sell-to-cover" tied to tax withholding on RSU vesting, which is routine and does not necessarily indicate a change in insider confidence. For retail investors, purchases typically carry more weight as bullish signals; routine tax-related sales like this are common and primarily administrative.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-05-19$9.01/sh−3,095$27,879→ 148,228 total
Footnotes (2)
- [F1]The Issuer has adopted a 'sell-to-cover' policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and release of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
- [F2]The weighted average sale price for the transaction reported was $9.0078, and the range of prices were between $8.7447 and $9.0104. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.